NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

I firmly believe we will not hold $1 post UK approval. My reasoning is the company has no cash to expand commercially or run any trials. Therefore the progress will be extremely slow. Moreover, given the patchy execution history of this management, no large investor would want to inject a significant chunk of capital at premium valuation (say over $1.5 or $2B market cap). Management will continue to sell C shares at a discount to keep the lights on. 4 years since data lock and no regulatory submissions outside UK (and that too without any clarity on when reimbursement submissions will be made in the UK) tells you everything you need to know.